Harvard Bioscience forms five-member scientific advisory board
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
Harvard Bioscience has formed a five-member scientific advisory board to guide its research, development and new product roadmaps, with quarterly meetings planned. The move follows Q2 revenue of $22.73 million that surpassed analyst estimates, plus an ownership filing showing a 5.20 percent stake. Investors await the Q3 earnings report on November 10, 2026, to gauge the operational impact.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.